Union Budget 2026: Finance Minister Eliminates Customs Duty on 17 Cancer-Related Drugs
India's Finance Minister announced in Union Budget 2026 the elimination of customs duty on 17 cancer-related drugs. This healthcare policy initiative aims to reduce treatment costs and improve accessibility of essential cancer medications for patients across the country.

*this image is generated using AI for illustrative purposes only.
India's Finance Minister has announced a major healthcare policy change in Union Budget 2026, eliminating customs duty on 17 cancer-related drugs. This significant move is designed to reduce the financial burden on cancer patients and improve access to essential medications.
Healthcare Policy Initiative
The announcement to remove customs duty on cancer-related drugs represents a targeted approach to healthcare affordability. By eliminating these duties, the government aims to make cancer treatment more accessible to patients across various economic segments.
Impact on Cancer Treatment Costs
The removal of customs duty on these 17 specific cancer-related drugs is expected to result in reduced medication costs for patients. This policy change addresses one of the key financial challenges faced by cancer patients and their families during treatment.
| Policy Details: | Information |
|---|---|
| Budget Year: | Union Budget 2026 |
| Number of Drugs: | 17 cancer-related drugs |
| Customs Duty: | Eliminated (0%) |
| Policy Focus: | Healthcare affordability |
Government's Healthcare Focus
This announcement reflects the government's continued emphasis on healthcare sector reforms and making medical treatment more affordable. The specific targeting of cancer-related drugs demonstrates recognition of the high costs associated with cancer treatment and the need for policy intervention to support patients.

































